Re: Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): A multicentre, randomised, double-blind, phase 3 trial

Samir S. Taneja

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)848-849
Number of pages2
JournalJournal of Urology
Volume193
Issue number3
DOIs
StatePublished - Mar 1 2015

ASJC Scopus subject areas

  • Urology

Cite this